Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prostate-specific targeting using PSA promoter-based lentiviral vectors.

D Yu1, D Chen, C Chiu

  • 1Division of Oral Biology and Medicine, UCLA School of Dentistry, 10833 Le Conte Avenue, Los Angeles, CA 90095-1668, USA.

Cancer Gene Therapy
|October 11, 2001
PubMed
Summary

A novel lentiviral vector utilizing the prostate-specific antigen promoter effectively targets prostate cancer cells. This system shows promise for gene therapy by specifically delivering therapeutic genes to cancer cells while sparing healthy tissues.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk analysis for outpatient experimental infection as a pathway for affordable RSV vaccine development.

NPJ vaccines·2025
Same author

Canadian Surgery Forum 2018: St. John's, NL Sept. 13-15, 2018.

Canadian journal of surgery. Journal canadien de chirurgie·2022
Same author

An artificial intelligence algorithm that differentiates anterior ethmoidal artery location on sinus computed tomography scans.

The Journal of laryngology and otology·2019
Same author

Chronic minocycline treatment improves hippocampal neuronal structure, NMDA receptor function, and memory processing in Fmr1 knockout mice.

Neurobiology of disease·2018
Same author

Investigating adverse events following immunisation with pneumococcal polysaccharide vaccine using electronic General Practice data.

Vaccine·2017
Same author

Impaired bidirectional NMDA receptor dependent synaptic plasticity in the dentate gyrus of adult female Fmr1 heterozygous knockout mice.

Neurobiology of disease·2016

Area of Science:

  • Oncology
  • Gene Therapy
  • Molecular Biology

Background:

  • The prostate-specific antigen (PSA) promoter offers tissue specificity for gene therapy but has low transcription efficiency.
  • Developing an effective gene vector for prostate cancer requires overcoming the limitations of PSA promoter activity.

Purpose of the Study:

  • To construct and evaluate a lentiviral vector system using the PSA promoter for prostate cancer gene therapy.
  • To assess the efficacy and specificity of PSA promoter-driven gene expression in prostate cancer cells.

Main Methods:

  • Construction of a human immunodeficiency virus (HIV)-1-based lentiviral vector carrying enhanced green fluorescent protein (EGFP) or diphtheria toxin A (DTA) gene.
  • In vitro testing of PSA promoter-driven gene expression and cell eradication.

Related Experiment Videos

  • In vivo studies using nude mice bearing prostate cancer xenografts to assess EGFP expression and tissue specificity.

    • Main Results:

    • The PSA promoter in a lentiviral vector demonstrated satisfactory efficacy and specificity in driving gene expression in prostate cells.
    • Diphtheria toxin A (DTA) expression specifically eradicated LNCaP prostate cancer cells in culture.
    • In vivo studies showed significant EGFP expression in prostate tumors but negligible expression in other tissues, confirming high specificity.

    Conclusions:

    • The PSA promoter-driven lentiviral vector is a potentially valuable tool for prostate cancer gene therapy.
    • This system exhibits high specificity and efficacy, offering a promising approach for treating metastatic prostate cancer.